Pitcher Ervin Santana will receive a $15.3 million qualifying offer from the Braves, Mark Bowman of MLB.com reports. As a result, the Braves will either get Santana back for one more year or receive draft pick compensation if he chooses to sign elsewhere.
Santana was hurt by being attached to draft pick compensation, going unsigned until mid-March, when the Braves signed the right-hander after pitchers Kris Medlen and Brandon Beachy each suffered an injury.
Santana, who turns 32 in December, finished with a 3.95 ERA and a 179/63 K/BB ratio in 196 innings for the Braves this past season. Though he struggled at times, he was able to bring his strikeout rate up to 22 percent, his highest rate since 2008 with the Angels.
Phillies COVID testing results revealed no new positives for the fourth straight day, the team announced this morning. As a result, they will resume their schedule tonight against the Yankees.
It’ll be the first game for the Phillies since last Sunday’s game against the Marlins. The Miami outbreak prompted the Phillies’ season to be shut down, but the lack of positive tests beyond team staff that had more direct contact with the visiting Marlins is an encouraging sign. The Phillies COVID testing strongly suggests that cross-team infection from on-the-field activity is not a significant problem. This could bode well for, say, the Brewers, who have been idled a few days due to the outbreak emerging on their would-be opponents this past weekend, the St. Louis Cardinals.
All of this, of course, puts the Phillies well behind their usual schedule. They’ve played just three games and have had minimal baseball activity in the past eight days. Whether that shows up in the performances of Jake Arrieta and Aaron Nola, tonight and tomorrow night’s starters, respectively, will be worth watching.
All in all, though, the Phillies COVID testing results are good news. And folks, we could use some good news right now.
UPDATE: The Marlins are negative too: